NPPA fixes retail price of 74 formulations
Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilizer, the Government of India has fixed the retail prices of the 74 scheduled formulations including those used to lower the levels of triglycerides in blood, to prevent heart attack and stroke, to treat high blood pressure, type 2 diabetes, and gastro-oesophageal...
Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilizer, the Government of India has fixed the retail prices of the 74 scheduled formulations including those used to lower the levels of triglycerides in blood, to prevent heart attack and stroke, to treat high blood pressure, type 2 diabetes, and gastro-oesophageal reflux disease.
This came in line with the decision of the 109th authority meeting dated 21.02.2023, where the authority discussed the new drug applications for price fixation under para 5 and 15 of DPCO 2013.
For more details, check out the link given below:
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd